VSIG2 antibody
Principal name
VSIG2 antibody
Alternative names for VSIG2 antibody
V-set and immunoglobulin domain-containing protein 2, CTH, CTXL, Cortical thymocyte-like protein, CT-like protein
Ncbi ID
NP_055127.2, NM_014312, NP_055127, NP_065264.2, BC099457, NM_020518
Available reactivities
Available hosts
Available applications
Flow Cytometry (F), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB), Paraffin Sections (P)
Background of VSIG2 antibody
- Kit Component:
- - KN319277G1, Vsig2 gRNA vector 1 in pCas-Guide vector
- KN319277G2, Vsig2 gRNA vector 2 in pCas-Guide vector
- KN319277D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Anti-VSIG2 mouse monoclonal antibody (TA502108) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY VSIG2(RC200170).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VSIG2 (RC200170, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VSIG2.
Western blot analysis of extracts (35ug) from 9 different cell lines by using anti-VSIG2 monoclonal antibody.
HEK293T cells transfected with either RC200170 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-VSIG2 antibody(TA502108), and then analyzed by flow cytometry.
Western blot analysis of extracts (35ug) from 9 different cell lines by using anti-VSIG2 monoclonal antibody.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VSIG2 (RC200170, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VSIG2.
HEK293T cells transfected with either RC200170 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-VSIG2 antibody(TA502124), and then analyzed by flow cytometry.
Immunohistochemical staining of paraffin-embedded Human prostate tissue within the normal limits using anti-VSIG2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA502125)
Anti-VSIG2 mouse monoclonal antibody (TA502125) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY VSIG2(RC200170).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VSIG2 (RC200170, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VSIG2.
Western blot analysis of extracts (35ug) from 9 different cell lines by using anti-VSIG2 monoclonal antibody (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human).
HEK293T cells transfected with either RC200170 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-VSIG2 antibody(TA502125), and then analyzed by flow cytometry.
Immunohistochemical staining of paraffin-embedded Human Kidney tissue within the normal limits using anti-VSIG2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA502161)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human breast tissue using anti-VSIG2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA502161)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VSIG2 (RC200170, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VSIG2.
HEK293T cells transfected with either RC200170 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-VSIG2 antibody(TA502161), and then analyzed by flow cytometry.
Anti-VSIG2 mouse monoclonal antibody (TA502162) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY VSIG2(RC200170).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VSIG2 (RC200170, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VSIG2.
Western blot analysis of extracts (35ug) from 9 different cell lines by using anti-VSIG2 monoclonal antibody.
HEK293T cells transfected with either RC200170 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-VSIG2 antibody(TA502162), and then analyzed by flow cytometry.
- Quick-Filters:
- Highly Validated (4)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA502108 | VSIG2 antibody |
||||||
| VSIG2 mouse monoclonal antibody, clone OTI1F8 (formerly 1F8) | |||||||
 |
Mouse | IgG2b | OTI1F8 | Purified | Hu | F, ICC/IF, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
 +3 additional images |
Highly validated antibody!
|
||||||
| TA502125 | VSIG2 antibody |
||||||
| VSIG2 mouse monoclonal antibody, clone OTI2D8 (formerly 2D8) | |||||||
 |
Mouse | IgG2a | OTI2D8 | Purified | Hu | F, ICC/IF, P, WB |
0.1 ml /
€379.00
|
| OriGene Technologies, Inc. | |||||||
| +4 additional images |
Highly validated antibody!
|
||||||
| TA502161 | VSIG2 antibody |
||||||
| VSIG2 mouse monoclonal antibody, clone OTI5A10 (formerly 5A10) | |||||||
 |
Mouse | IgG1 | OTI5A10 | Purified | Hu | F, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +3 additional images |
Highly validated antibody!
|
||||||
| TA502162 | VSIG2 antibody |
||||||
| VSIG2 mouse monoclonal antibody, clone OTI11B3 (formerly 11B3) | |||||||
 |
Mouse | IgG2b | OTI11B3 | Purified | Hu | F, ICC/IF, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +3 additional images |
Highly validated antibody!
|
||||||
| TA502124 | VSIG2 antibody |
||||||
| VSIG2 mouse monoclonal antibody, clone OTI1H2 (formerly 1H2) | |||||||
 |
Mouse | IgG1 | OTI1H2 | Purified | Hu | F, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|
||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP300170 | VSIG2 |
||||
| Recombinant protein of human V-set and immunoglobulin domain containing 2 (VSIG2) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP720453 | VSIG2 |
||||
| Recombinant protein of human V-set and immunoglobulin domain containing 2 (VSIG2) | |||||
 |
Human | > 95 % Preparation: . Purity Detail: >95% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
10 µg /
€299.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY415368 | VSIG2 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR202858L2V | Lenti ORF particles, Vsig2 (GFP-tagged) - Mouse V-set and immunoglobulin domain containing 2 (cDNA clone MGC:117653 IMAGE:30789633), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,240.00
|
|
| OriGene Technologies, Inc. | ||
| MR216309L2V | Lenti ORF particles, Vsig2 (GFP-tagged) - Mouse V-set and immunoglobulin domain containing 2 (Vsig2), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR202858L1V | Lenti ORF particles, Vsig2 (Myc-DDK-tagged) - Mouse V-set and immunoglobulin domain containing 2 (cDNA clone MGC:117653 IMAGE:30789633), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,110.00
|
|
| OriGene Technologies, Inc. | ||
| MR216309L1V | Lenti ORF particles, Vsig2 (Myc-DDK-tagged) - Mouse V-set and immunoglobulin domain containing 2 (Vsig2), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
